CD99 is a protein found on the surface of many types of cells. Pathologists test for CD99 to help identify small, round-cell tumors, especially Ewing sarcoma. Almost all Ewing sarcomas are strongly CD99-positive. Many other tumors are also positive, so pathologists never use CD99 alone to make a diagnosis.
CD99 is a test result, not a diagnosis. It is one of the stains a pathologist uses to work out what type of cells are present. This article explains why pathologists test for CD99 and what a positive or negative result means in your pathology report.
CD99 helps cells stick to each other and helps white blood cells move through blood vessel walls. In normal tissue, it is found on several cell types. These include developing immune cells in the thymus and bone marrow, the endothelial cells that line blood vessels, and some cells in the ovary and testis.
Pathologists test for CD99 using immunohistochemistry (IHC). In this test, a thin slice of tissue on a glass slide is treated with an antibody that sticks to CD99. A chemical reaction then colors any cell containing CD99 brown, making it visible under the microscope.
The pattern of staining matters. In Ewing sarcoma, CD99 typically outlines the edge of every tumor cell in a strong, even pattern. Pathologists call this diffuse membranous staining. Other tumors are more likely to show weaker or patchy staining, or staining inside the cell rather than at its edge.
Pathologists use CD99 to confirm what type of cells are present. It does not predict how a tumor will respond to a particular treatment. Pathologists most often test for CD99 when a tumor is made of small, round cells with little cytoplasm. Many different tumors share this appearance, and CD99 is one of the stains used to distinguish them.
Tumors that are often positive for CD99 include:
A positive result means the tested cells contain CD99. Your report may describe the result as “positive,” “reactive,” or say that CD99 shows “membranous” staining. In a small round cell tumor, strong and diffuse membranous staining supports Ewing sarcoma. Because many other tumors are positive, pathologists interpret the result alongside other stains.
Ewing sarcoma is usually confirmed with a molecular test that finds a gene change involving EWSR1. CD99 is a helpful first clue, while the molecular test confirms the diagnosis.
A negative result means the tested cells do not contain CD99. Your report may describe the result as “negative,” “nonreactive,” or “not expressed.” In a small round cell tumor, a completely negative result makes Ewing sarcoma very unlikely.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name